PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of microrevMicrobiol Mol Biol Rev ArchivePermissionsJournals.ASM.orgMMBR ArticleJournal InfoAuthorsReviewers
 
Microbiol Rev. 1996 June; 60(2): 267–279.
PMCID: PMC239443

Branhamella catarrhalis: epidemiology, surface antigenic structure, and immune response.

Abstract

Over the past decade, Branhamella catarrhalis has emerged as an important human pathogen. The bacterium is a common cause of otitis media in children and of lower respiratory tract infections in adults with chronic obstructive pulmonary disease. B. catarrhalis is exclusively a human pathogen. It colonizes the respiratory tract of a small proportion of adults and a larger proportion of children. Studies involving restriction enzyme analysis of genomic DNA show that colonization is a dynamic process, with the human host eliminating and acquiring new strains frequently. The surface of B. catarrhalis contains outer membrane proteins, lipooligosaccharide, and pili. The genes which encode several outer membrane proteins have been cloned, and some of these proteins are being studied as potential vaccine antigens. Analysis of the immune response has been limited by the lack of an adequate animal model of B. catarrhalis infection. New information regarding outer membrane structure should guide studies of the human immune response to B. catarrhalis. Immunoassays which specifically detect antibodies to determinants exposed on the bacterial surface will elucidate the most relevant immune response. The recognition of B. catarrhalis as an important human pathogen has stimulated research on the epidemiology and surface structures of the bacterium. Future studies to understand the mechanisms of infection and to elucidate the human immune response to infection hold promise of developing new methods to treat and prevent infections caused by B. catarrhalis.

Full Text

The Full Text of this article is available as a PDF (620K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Ahmad F, McLeod DT, Power JT, Calder MA. Branhamella catarrhalis prevalence in a hospital population. J Hosp Infect. 1985 Mar;6(1):71–74. [PubMed]
  • Ahmed K. Fimbriae of Branhamella catarrhalis as possible mediators of adherence to pharyngeal epithelial cells. APMIS. 1992 Dec;100(12):1066–1072. [PubMed]
  • Ahmed K, Masaki H, Dai TC, Ichinose A, Utsunomiya Y, Tao M, Nagatake T, Matsumoto K. Expression of fimbriae and host response in Branhamella catarrhalis respiratory infections. Microbiol Immunol. 1994;38(10):767–771. [PubMed]
  • Ahmed K, Rikitomi N, Ichinose A, Matsumoto K. Possible presence of a capsule in Branhamella catarrhalis. Microbiol Immunol. 1991;35(5):361–366. [PubMed]
  • Ahmed K, Rikitomi N, Matsumoto K. Fimbriation, hemagglutination and adherence properties of fresh clinical isolates of Branhamella catarrhalis. Microbiol Immunol. 1992;36(10):1009–1017. [PubMed]
  • Ahmed K, Rikitomi N, Nagatake T, Matsumoto K. Electron microscopic observation of Branhamella catarrhalis. Microbiol Immunol. 1990;34(12):967–975. [PubMed]
  • Aitken JM, Thornley PE. Isolation of Branhamella catarrhalis from sputum and tracheal aspirate. J Clin Microbiol. 1983 Nov;18(5):1262–1263. [PMC free article] [PubMed]
  • Alaeus A, Stiernstedt G. Branhamella catarrhalis septicemia in an immunocompetent adult. Scand J Infect Dis. 1991;23(1):115–116. [PubMed]
  • Aniansson G, Alm B, Andersson B, Larsson P, Nylén O, Peterson H, Rignér P, Svanborg M, Svanborg C. Nasopharyngeal colonization during the first year of life. J Infect Dis. 1992 Jun;165 (Suppl 1):S38–S42. [PubMed]
  • Aspin MM, Hoberman A, McCarty J, McLinn SE, Aronoff S, Lang DJ, Arrieta A. Comparative study of the safety and efficacy of clarithromycin and amoxicillin-clavulanate in the treatment of acute otitis media in children. J Pediatr. 1994 Jul;125(1):136–141. [PubMed]
  • Barenkamp SJ. Protection by serum antibodies in experimental nontypable Haemophilus influenzae otitis media. Infect Immun. 1986 May;52(2):572–578. [PMC free article] [PubMed]
  • Bartos LC, Murphy TF. Comparison of the outer membrane proteins of 50 strains of Branhamella catarrhalis. J Infect Dis. 1988 Oct;158(4):761–765. [PubMed]
  • Beaulieu D, Scriver S, Bergeron MG, Low DE, Parr TR, Jr, Patterson JE, Matlow A, Roy PH. Epidemiological typing of Moraxella catarrhalis by using DNA probes. J Clin Microbiol. 1993 Mar;31(3):736–739. [PMC free article] [PubMed]
  • Beucher M, Sparling PF. Cloning, sequencing, and characterization of the gene encoding FrpB, a major iron-regulated, outer membrane protein of Neisseria gonorrhoeae. J Bacteriol. 1995 Apr;177(8):2041–2049. [PMC free article] [PubMed]
  • Bhushan R, Craigie R, Murphy TF. Molecular cloning and characterization of outer membrane protein E of Moraxella (Branhamella) catarrhalis. J Bacteriol. 1994 Nov;176(21):6636–6643. [PMC free article] [PubMed]
  • Black AJ, Wilson TS. Immunoglobulin G (IgG) serological response to Branhamella catarrhalis in patients with acute bronchopulmonary infections. J Clin Pathol. 1988 Mar;41(3):329–333. [PMC free article] [PubMed]
  • Boyle FM, Georghiou PR, Tilse MH, McCormack JG. Branhamella (Moraxella) catarrhalis: pathogenic significance in respiratory infections. Med J Aust. 1991 May 6;154(9):592–596. [PubMed]
  • Brorson JE, Axelsson A, Holm SE. Studies on Branhamella Catarrhalis (Neisseria catarrhalis) with special reference to maxillary sinusitis. Scand J Infect Dis. 1976;8(3):151–155. [PubMed]
  • Brunham RC, Plummer FA, Stephens RS. Bacterial antigenic variation, host immune response, and pathogen-host coevolution. Infect Immun. 1993 Jun;61(6):2273–2276. [PMC free article] [PubMed]
  • Burman LA, Leinonen M, Trollfors B. Use of serology to diagnose pneumonia caused by nonencapsulated Haemophilus influenzae and Moraxella catarrhalis. J Infect Dis. 1994 Jul;170(1):220–222. [PubMed]
  • Campagnari AA, Gupta MR, Dudas KC, Murphy TF, Apicella MA. Antigenic diversity of lipooligosaccharides of nontypable Haemophilus influenzae. Infect Immun. 1987 Apr;55(4):882–887. [PMC free article] [PubMed]
  • Campagnari AA, Shanks KL, Dyer DW. Growth of Moraxella catarrhalis with human transferrin and lactoferrin: expression of iron-repressible proteins without siderophore production. Infect Immun. 1994 Nov;62(11):4909–4914. [PMC free article] [PubMed]
  • Campagnari AA, Spinola SM, Lesse AJ, Kwaik YA, Mandrell RE, Apicella MA. Lipooligosaccharide epitopes shared among gram-negative non-enteric mucosal pathogens. Microb Pathog. 1990 May;8(5):353–362. [PubMed]
  • Carson RT, McDonald DF, Kehoe MA, Calvert JE. Influence of Gm allotype on the IgG subclass response to streptococcal M protein and outer membrane proteins of Moraxella catarrhalis. Immunology. 1994 Sep;83(1):107–113. [PubMed]
  • Catlin BW. Branhamella catarrhalis: an organism gaining respect as a pathogen. Clin Microbiol Rev. 1990 Oct;3(4):293–320. [PMC free article] [PubMed]
  • Chapman AJ, Jr, Musher DM, Jonsson S, Clarridge JE, Wallace RJ., Jr Development of bactericidal antibody during Branhamella catarrhalis infection. J Infect Dis. 1985 May;151(5):878–882. [PubMed]
  • Chonmaitree T, Owen MJ, Patel JA, Hedgpeth D, Horlick D, Howie VM. Effect of viral respiratory tract infection on outcome of acute otitis media. J Pediatr. 1992 Jun;120(6):856–862. [PubMed]
  • Choo PW, Gantz NM. Branhamella catarrhalis pneumonia with bacteremia. South Med J. 1989 Oct;82(10):1317–1318. [PubMed]
  • Chung MH, Enrique R, Lim DJ, De Maria TF. Moraxella (Branhamella) catarrhalis-induced experimental otitis media in the chinchilla. Acta Otolaryngol. 1994 Jul;114(4):415–422. [PubMed]
  • Cimolai N, Adderley RJ. Branhamella catarrhalis bacteremia in children. Acta Paediatr Scand. 1989 May;78(3):465–468. [PubMed]
  • Collazos J, de Miguel J, Ayarza R. Moraxella catarrhalis bacteremic pneumonia in adults: two cases and review of the literature. Eur J Clin Microbiol Infect Dis. 1992 Mar;11(3):237–240. [PubMed]
  • Contreras MR, Ash SR, Swick SD, Grutzner J. Peritonitis due to Moraxella (Branhamella) catarrhalis in a diabetic patient receiving peritoneal dialysis. South Med J. 1993 May;86(5):589–590. [PubMed]
  • Cook PP, Hecht DW, Snydman DR. Nosocomial Branhamella catarrhalis in a paediatric intensive care unit: risk factors for disease. J Hosp Infect. 1989 Apr;13(3):299–307. [PubMed]
  • Cooke RP, Williams R, Bannister CM. Shunt-associated ventriculitis caused by Branhamella catarrhalis. J Hosp Infect. 1990 Feb;15(2):197–198. [PubMed]
  • Craig DB, Wehrle PA. Branhamella catarrhalis septic arthritis. J Rheumatol. 1983 Dec;10(6):985–986. [PubMed]
  • Davies BI, Maesen FP. Epidemiological and bacteriological findings on Branhamella catarrhalis respiratory infections in The Netherlands. Drugs. 1986;31 (Suppl 3):28–33. [PubMed]
  • Del Beccaro MA, Mendelman PM, Inglis AF, Richardson MA, Duncan NO, Clausen CR, Stull TL. Bacteriology of acute otitis media: a new perspective. J Pediatr. 1992 Jan;120(1):81–84. [PubMed]
  • Denamur E, Picard-Pasquier N, Mura C, Picard B, Orfila J, Krishnamoorthy R. Comparison of molecular epidemiological tools for Branhamella catarrhalis typing. Res Microbiol. 1991 Jun;142(5):585–589. [PubMed]
  • Dickinson DP, Loos BG, Dryja DM, Bernstein JM. Restriction fragment mapping of Branhamella catarrhalis: a new tool for studying the epidemiology of this middle ear pathogen. J Infect Dis. 1988 Jul;158(1):205–208. [PubMed]
  • Doern GV, Gantz NM. Isolation of Branhamella (Neisseria) catarrhalis from men with urethritis. Sex Transm Dis. 1982 Oct-Dec;9(4):202–204. [PubMed]
  • Doern GV, Miller MJ, Winn RE. Branhamella (Neisseria) catarrhalis systemic disease in humans. Case reports and review of the literature. Arch Intern Med. 1981 Nov;141(12):1690–1692. [PubMed]
  • Douer D, Danziger Y, Pinkhas J. Neisseria catarrhalis endocarditis. Ann Intern Med. 1977 Jan;86(1):116–116. [PubMed]
  • Doyle WJ. Animal models of otitis media: other pathogens. Pediatr Infect Dis J. 1989 Jan;8(1 Suppl):S45–S47. [PubMed]
  • Dyson C, Poonyth HD, Watkinson M, Rose SJ. Life threatening Branhamella catarrhalis pneumonia in young infants. J Infect. 1990 Nov;21(3):305–307. [PubMed]
  • Edebrink P, Jansson PE, Rahman MM, Widmalm G, Holme T, Rahman M, Weintraub A. Structural studies of the O-polysaccharide from the lipopolysaccharide of Moraxella (Branhamella) catarrhalis serotype A (strain ATCC 25238). Carbohydr Res. 1994 May 5;257(2):269–284. [PubMed]
  • Ejlertsen T, Thisted E, Ebbesen F, Olesen B, Renneberg J. Branhamella catarrhalis in children and adults. A study of prevalence, time of colonisation, and association with upper and lower respiratory tract infections. J Infect. 1994 Jul;29(1):23–31. [PubMed]
  • Eliasson I. Serological identification of Branhamella catarrhalis. Serological evidence for infection. Drugs. 1986;31 (Suppl 3):7–10. [PubMed]
  • Engleberg NC, Pearlman E, Eisenstein BI. Legionella pneumophila surface antigens cloned and expressed in Escherichia coli are translocated to the host cell surface and interact with specific anti-Legionella antibodies. J Bacteriol. 1984 Oct;160(1):199–203. [PMC free article] [PubMed]
  • Faden H, Bernstein J, Brodsky L, Stanievich J, Krystofik D, Shuff C, Hong JJ, Ogra PL. Otitis media in children. I. The systemic immune response to nontypable Hemophilus influenzae. J Infect Dis. 1989 Dec;160(6):999–1004. [PubMed]
  • Faden H, Bernstein J, Brodsky L, Stanievich J, Ogra PL. Effect of prior antibiotic treatment on middle ear disease in children. Ann Otol Rhinol Laryngol. 1992 Jan;101(1):87–91. [PubMed]
  • Faden H, Waz MJ, Bernstein JM, Brodsky L, Stanievich J, Ogra PL. Nasopharyngeal flora in the first three years of life in normal and otitis-prone children. Ann Otol Rhinol Laryngol. 1991 Aug;100(8):612–615. [PubMed]
  • Faden H, Harabuchi Y, Hong JJ. Epidemiology of Moraxella catarrhalis in children during the first 2 years of life: relationship to otitis media. J Infect Dis. 1994 Jun;169(6):1312–1317. [PubMed]
  • Faden H, Hong J, Murphy T. Immune response to outer membrane antigens of Moraxella catarrhalis in children with otitis media. Infect Immun. 1992 Sep;60(9):3824–3829. [PMC free article] [PubMed]
  • Faden H, Hong JJ, Pahade N. Immune response to Moraxella catarrhalis in children with otitis media: opsonophagocytosis with antigen-coated latex beads. Ann Otol Rhinol Laryngol. 1994 Jul;103(7):522–524. [PubMed]
  • Fomsgaard JS, Fomsgaard A, Høiby N, Bruun B, Galanos C. Comparative immunochemistry of lipopolysaccharides from Branhamella catarrhalis strains. Infect Immun. 1991 Sep;59(9):3346–3349. [PMC free article] [PubMed]
  • Forsgren A, Penta A, Schlossman SF, Tedder TF. Branhamella catarrhalis activates human B lymphocytes following interactions with surface IgD and class I major histocompatibility complex antigens. Cell Immunol. 1988 Mar;112(1):78–88. [PubMed]
  • Gan VN, Kusmiesz H, Shelton S, Nelson JD. Comparative evaluation of loracarbef and amoxicillin-clavulanate for acute otitis media. Antimicrob Agents Chemother. 1991 May;35(5):967–971. [PMC free article] [PubMed]
  • Gehanno P, Berche P, Boucot I, Lambert-Zechovsky N, Bingen E, Gres JJ, Rollin C. Comparative efficacy and safety of cefprozil and amoxycillin/clavulanate in the treatment of acute otitis media in children. J Antimicrob Chemother. 1994 Jun;33(6):1209–1218. [PubMed]
  • Giebink GS, Berzins IK, Marker SC, Schiffman G. Experimental otitis media after nasal inoculation of Streptococcus pneumoniae and influenza A virus in chinchillas. Infect Immun. 1980 Nov;30(2):445–450. [PMC free article] [PubMed]
  • Giebink GS, Berzins IK, Schiffman G, Quie PG. Experimental otitis media in chinchillas following nasal colonization with type 7F Streptococcus pneumoniae: prevention after vaccination with pneumococcal capsular polysaccharide. J Infect Dis. 1979 Nov;140(5):716–723. [PubMed]
  • Gilleland HE, Jr, Gilleland LB, Matthews-Greer JM. Outer membrane protein F preparation of Pseudomonas aeruginosa as a vaccine against chronic pulmonary infection with heterologous immunotype strains in a rat model. Infect Immun. 1988 May;56(5):1017–1022. [PMC free article] [PubMed]
  • Gilleland HE, Jr, Parker MG, Matthews JM, Berg RD. Use of a purified outer membrane protein F (porin) preparation of Pseudomonas aeruginosa as a protective vaccine in mice. Infect Immun. 1984 Apr;44(1):49–54. [PMC free article] [PubMed]
  • Goldblatt D, Scadding GK, Lund VJ, Wade AM, Turner MW, Pandey JP. Association of Gm allotypes with the antibody response to the outer membrane proteins of a common upper respiratory tract organism, Moraxella catarrhalis. J Immunol. 1994 Dec 1;153(11):5316–5320. [PubMed]
  • Goldblatt D, Turner MW, Levinsky RJ. Branhamella catarrhalis: antigenic determinants and the development of the IgG subclass response in childhood. J Infect Dis. 1990 Nov;162(5):1128–1135. [PubMed]
  • Goldschneider I, Gotschlich EC, Artenstein MS. Human immunity to the meningococcus. I. The role of humoral antibodies. J Exp Med. 1969 Jun 1;129(6):1307–1326. [PMC free article] [PubMed]
  • Gray LD, Van Scoy RE, Anhalt JP, Yu PK. Wound infection caused by Branhamella catarrhalis. J Clin Microbiol. 1989 May;27(5):818–820. [PMC free article] [PubMed]
  • Green BA, Vazquez ME, Zlotnick GW, Quigley-Reape G, Swarts JD, Green I, Cowell JL, Bluestone CD, Doyle WJ. Evaluation of mixtures of purified Haemophilus influenzae outer membrane proteins in protection against challenge with nontypeable H. influenzae in the chinchilla otitis media model. Infect Immun. 1993 May;61(5):1950–1957. [PMC free article] [PubMed]
  • Gulig PA, McCracken GH, Jr, Frisch CF, Johnston KH, Hansen EJ. Antibody response of infants to cell surface-exposed outer membrane proteins of Haemophilus influenzae type b after systemic Haemophilus disease. Infect Immun. 1982 Jul;37(1):82–88. [PMC free article] [PubMed]
  • Guthrie R, Bakenhaster K, Nelson R, Woskobnick R. Branhamella catarrhalis sepsis: a case report and review of the literature. J Infect Dis. 1988 Oct;158(4):907–908. [PubMed]
  • Haase EM, Campagnari AA, Sarwar J, Shero M, Wirth M, Cumming CU, Murphy TF. Strain-specific and immunodominant surface epitopes of the P2 porin protein of nontypeable Haemophilus influenzae. Infect Immun. 1991 Apr;59(4):1278–1284. [PMC free article] [PubMed]
  • Haase EM, Yi K, Morse GD, Murphy TF. Mapping of bactericidal epitopes on the P2 porin protein of nontypeable Haemophilus influenzae. Infect Immun. 1994 Sep;62(9):3712–3722. [PMC free article] [PubMed]
  • Haddad J, Le Faou A, Simeoni U, Messer J. Hospital-acquired bronchopulmonary infection in premature infants due to Branhamella catarrhalis. J Hosp Infect. 1986 May;7(3):301–302. [PubMed]
  • Hager H, Verghese A, Alvarez S, Berk SL. Branhamella catarrhalis respiratory infections. Rev Infect Dis. 1987 Nov-Dec;9(6):1140–1149. [PubMed]
  • Harkness RE, Guimond MJ, McBey BA, Klein MH, Percy DH, Croy BA. Branhamella catarrhalis pathogenesis in SCID and SCID/beige mice. Brief report. APMIS. 1993 Oct;101(10):805–810. [PubMed]
  • Hellio R, Guibourdenche M, Collatz E, Riou JY. The envelope structure of Branhamella catarrhalis as studied by transmission electron microscopy. Ann Inst Pasteur Microbiol. 1988 Sep-Oct;139(5):515–525. [PubMed]
  • Helminen ME, Maciver I, Latimer JL, Cope LD, McCracken GH, Jr, Hansen EJ. A major outer membrane protein of Moraxella catarrhalis is a target for antibodies that enhance pulmonary clearance of the pathogen in an animal model. Infect Immun. 1993 May;61(5):2003–2010. [PMC free article] [PubMed]
  • Helminen ME, Maciver I, Latimer JL, Klesney-Tait J, Cope LD, Paris M, McCracken GH, Jr, Hansen EJ. A large, antigenically conserved protein on the surface of Moraxella catarrhalis is a target for protective antibodies. J Infect Dis. 1994 Oct;170(4):867–872. [PubMed]
  • Helminen ME, Maciver I, Paris M, Latimer JL, Lumbley SL, Cope LD, McCracken GH, Jr, Hansen EJ. A mutation affecting expression of a major outer membrane protein of Moraxella catarrhalis alters serum resistance and survival in vivo. J Infect Dis. 1993 Nov;168(5):1194–1201. [PubMed]
  • Saito H, Anaissie EJ, Khardori N, Bodey GP. Branhamella catarrhalis septicemia in patients with leukemia. Cancer. 1988 Jun 1;61(11):2315–2317. [PubMed]
  • Hol C, Verduin CM, van Dijke E, Verhoef J, van Dijk H. Complement resistance in Branhamella (Moraxella) catarrhalis. Lancet. 1993 May 15;341(8855):1281–1281. [PubMed]
  • Hsiao CB, Sethi S, Murphy TF. Outer membrane protein CD of Branhamella catarrhalis: sequence conservation in strains recovered from the human respiratory tract. Microb Pathog. 1995 Oct;19(4):215–225. [PubMed]
  • Ikram RB, Nixon M, Aitken J, Wells E. A prospective study of isolation of Moraxella catarrhalis in a hospital during the winter months. J Hosp Infect. 1993 Sep;25(1):7–14. [PubMed]
  • Ioannidis JP, Worthington M, Griffiths JK, Snydman DR. Spectrum and significance of bacteremia due to Moraxella catarrhalis. Clin Infect Dis. 1995 Aug;21(2):390–397. [PubMed]
  • Jeanteur D, Lakey JH, Pattus F. The bacterial porin superfamily: sequence alignment and structure prediction. Mol Microbiol. 1991 Sep;5(9):2153–2164. [PubMed]
  • Johnson CE, Carlin SA, Super DM, Rehmus JM, Roberts DG, Christopher NC, Whitwell JK, Shurin PA. Cefixime compared with amoxicillin for treatment of acute otitis media. J Pediatr. 1991 Jul;119(1 Pt 1):117–122. [PubMed]
  • Jönsson I, Holme T, Krook A, Thorén M. Serological cross-reactions between Moraxella (Branhamella) catarrhalis and other oropharyngeal bacteria. Eur J Clin Microbiol Infect Dis. 1993 Apr;12(4):289–293. [PubMed]
  • Jordan KL, Berk SH, Berk SL. A comparison of serum bactericidal activity and phenotypic characteristics of bacteremic, pneumonia-causing strains, and colonizing strains of Branhamella catarrhalis. Am J Med. 1990 May 14;88(5A):28S–32S. [PubMed]
  • Jousimies-Somer HR, Savolainen S, Ylikoski JS. Comparison of the nasal bacterial floras in two groups of healthy subjects and in patients with acute maxillary sinusitis. J Clin Microbiol. 1989 Dec;27(12):2736–2743. [PMC free article] [PubMed]
  • Karjalainen H, Koskela M, Luotonen J, Herva E, Sipilä P. Occurrences of antibodies against Streptococcus pneumoniae, Haemophilus influenzae and Branhamella catarrhalis in middle ear effusion and serum during the course of acute otitis media. Acta Otolaryngol. 1991;111(1):112–119. [PubMed]
  • Karjalainen H, Koskela M, Luotonen J, Sipilä P. Secretory antibodies specific to Streptococcus pneumoniae, Haemophilus influenzae and Branhamella catarrhalis in middle ear effusion during acute otitis media. Acta Otolaryngol. 1991;111(3):524–529. [PubMed]
  • Kawakami Y, Segawa K, Kanai M. A case of acute catarrhal conjunctivitis due to Branhamella catarrhalis. Microbiol Immunol. 1983;27(7):641–643. [PubMed]
  • Kawakami Y, Ueno I, Katsuyama T, Furihata K, Matsumoto H. Restriction fragment length polymorphism (RFLP) of genomic DNA of Moraxella (Branhamella) catarrhalis isolates in a hospital. Microbiol Immunol. 1994;38(11):891–895. [PubMed]
  • Klein JO. Otitis media. Clin Infect Dis. 1994 Nov;19(5):823–833. [PubMed]
  • Klingman KL, Murphy TF. Purification and characterization of a high-molecular-weight outer membrane protein of Moraxella (Branhamella) catarrhalis. Infect Immun. 1994 Apr;62(4):1150–1155. [PMC free article] [PubMed]
  • Klingman KL, Pye A, Murphy TF, Hill SL. Dynamics of respiratory tract colonization by Branhamella catarrhalis in bronchiectasis. Am J Respir Crit Care Med. 1995 Sep;152(3):1072–1078. [PubMed]
  • Korppi M, Katila ML, Jäskeläinen J, Leinonen M. Role of Moraxella (Branhamella) catarrhalis as a respiratory pathogen in children. Acta Paediatr. 1992 Dec;81(12):993–996. [PubMed]
  • Kostiala AA, Honkanen T. Branhamella catarrhalis as a cause of acute purulent pericarditis. J Infect. 1989 Nov;19(3):291–292. [PubMed]
  • LANCEFIELD RC. Current knowledge of type-specific M antigens of group A streptococci. J Immunol. 1962 Sep;89:307–313. [PubMed]
  • Leach AJ, Boswell JB, Asche V, Nienhuys TG, Mathews JD. Bacterial colonization of the nasopharynx predicts very early onset and persistence of otitis media in Australian aboriginal infants. Pediatr Infect Dis J. 1994 Nov;13(11):983–989. [PubMed]
  • Leinonen M, Luotonen J, Herva E, Valkonen K, Mäkelä PH. Preliminary serologic evidence for a pathogenic role of Branhamella catarrhalis. J Infect Dis. 1981 Dec;144(6):570–574. [PubMed]
  • Loeb MR. Immunoblot method for identifying surface components, determining their cross-reactivity, and investigating cell topology: results with Haemophilus influenzae type b. Anal Biochem. 1984 Nov 15;143(1):196–204. [PubMed]
  • Loeb MR, Woodin KA. Cross-reactivity of surface-exposed epitopes of outer membrane antigens of Haemophilus influenzae type b. Infect Immun. 1987 Dec;55(12):2977–2983. [PMC free article] [PubMed]
  • Lue YA, Simms DH, Ubriani R, Pfeiffer NC, Gromisch DS. Ophthalmia neonatorum caused by penicillin-resistant Branhamella Catarrhalis. N Y State J Med. 1981 Nov;81(12):1775–1776. [PubMed]
  • Lundgren K, Ingvarsson L. Acute otitis media in Sweden. Role of Branhamella catarrhalis and the rationale for choice of antimicrobial therapy. Drugs. 1986;31 (Suppl 3):125–131. [PubMed]
  • Maciver I, Unhanand M, McCracken GH, Jr, Hansen EJ. Effect of immunization of pulmonary clearance of Moraxella catarrhalis in an animal model. J Infect Dis. 1993 Aug;168(2):469–472. [PubMed]
  • Marrs CF, Weir S. Pili (fimbriae) of Branhamella species. Am J Med. 1990 May 14;88(5A):36S–40S. [PubMed]
  • Maslow JN, Mulligan ME, Arbeit RD. Molecular epidemiology: application of contemporary techniques to the typing of microorganisms. Clin Infect Dis. 1993 Aug;17(2):153–164. [PubMed]
  • Masoud H, Perry MB, Richards JC. Characterization of the lipopolysaccharide of Moraxella catarrhalis. Structural analysis of the lipid A from M. catarrhalis serotype A lipopolysaccharide. Eur J Biochem. 1994 Feb 15;220(1):209–216. [PubMed]
  • Matthews-Greer JM, Gilleland HE., Jr Outer membrane protein F (porin) preparation of Pseudomonas aeruginosa as a protective vaccine against heterologous immunotype strains in a burned mouse model. J Infect Dis. 1987 Jun;155(6):1282–1291. [PubMed]
  • McKenzie H, Morgan MG, Jordens JZ, Enright MC, Bain M. Characterisation of hospital isolates of Moraxella (Branhamella) catarrhalis by SDS-PAGE of whole-cell proteins, immunoblotting and restriction-endonuclease analysis. J Med Microbiol. 1992 Jul;37(1):70–76. [PubMed]
  • McLeod DT, Ahmad F, Capewell S, Croughan MJ, Calder MA, Seaton A. Increase in bronchopulmonary infection due to branhamella catarrhalis. Br Med J (Clin Res Ed) 1986 Apr 26;292(6528):1103–1105. [PMC free article] [PubMed]
  • Melendez PR, Johnson RH. Bacteremia and septic arthritis caused by Moraxella catarrhalis. Rev Infect Dis. 1991 May-Jun;13(3):428–429. [PubMed]
  • Morgan MG, McKenzie H, Enright MC, Bain M, Emmanuel FX. Use of molecular methods to characterize Moraxella catarrhalis strains in a suspected outbreak of nosocomial infection. Eur J Clin Microbiol Infect Dis. 1992 Apr;11(4):305–312. [PubMed]
  • Murphy TF, Bartos LC. Surface-exposed and antigenically conserved determinants of outer membrane proteins of Branhamella catarrhalis. Infect Immun. 1989 Oct;57(10):2938–2941. [PMC free article] [PubMed]
  • Murphy TF, Kirkham C, Lesse AJ. The major heat-modifiable outer membrane protein CD is highly conserved among strains of Branhamella catarrhalis. Mol Microbiol. 1993 Oct;10(1):87–97. [PubMed]
  • Murphy TF, Loeb MR. Isolation of the outer membrane of Branhamella catarrhalis. Microb Pathog. 1989 Mar;6(3):159–174. [PubMed]
  • Murphy TF, Sethi S. Bacterial infection in chronic obstructive pulmonary disease. Am Rev Respir Dis. 1992 Oct;146(4):1067–1083. [PubMed]
  • Nicotra B, Rivera M, Luman JI, Wallace RJ., Jr Branhamella catarrhalis as a lower respiratory tract pathogen in patients with chronic lung disease. Arch Intern Med. 1986 May;146(5):890–893. [PubMed]
  • Nikaido H, Saier MH., Jr Transport proteins in bacteria: common themes in their design. Science. 1992 Nov 6;258(5084):936–942. [PubMed]
  • Ninane G, Joly J, Kraytman M. Bronchopulmonary infection due to Branhamella catarrhalis: 11 cases assessed by transtracheal puncture. Br Med J. 1978 Feb 4;1(6108):276–278. [PMC free article] [PubMed]
  • Noel GJ, Barenkamp SJ, St Geme JW, 3rd, Haining WN, Mosser DM. High-molecular-weight surface-exposed proteins of Haemophilus influenzae mediate binding to macrophages. J Infect Dis. 1994 Feb;169(2):425–429. [PubMed]
  • Onofrio JM, Shulkin AN, Heidbrink PJ, Toews GB, Pierce AK. Pulmonary clearance and phagocytic cell response to normal pharyngeal flora. Am Rev Respir Dis. 1981 Feb;123(2):222–225. [PubMed]
  • Owen MJ, Anwar R, Nguyen HK, Swank PR, Bannister ER, Howie VM. Efficacy of cefixime in the treatment of acute otitis media in children. Am J Dis Child. 1993 Jan;147(1):81–86. [PubMed]
  • Patterson JE, Patterson TF, Farrel P, Hierholzer WJ, Jr, Zervos MJ. Evaluation of restriction endonuclease analysis as an epidemiologic typing system for Branhamella catarrhalis. J Clin Microbiol. 1989 May;27(5):944–946. [PMC free article] [PubMed]
  • Patterson TF, Patterson JE, Masecar BL, Barden GE, Hierholzer WJ, Jr, Zervos MJ. A nosocomial outbreak of Branhamella catarrhalis confirmed by restriction endonuclease analysis. J Infect Dis. 1988 May;157(5):996–1001. [PubMed]
  • Picard B, Goullet P, Denamur E, Suermondt G. Esterase electrophoresis: a molecular tool for studying the epidemiology of Branhamella catarrhalis nosocomial infection. Epidemiol Infect. 1989 Dec;103(3):547–554. [PMC free article] [PubMed]
  • Pollard JA, Wallace RJ, Jr, Nash DR, Luman JI, Wilson RW. Incidence of Branhamella catarrhalis in the sputa of patients with chronic lung disease. Drugs. 1986;31 (Suppl 3):103–108. [PubMed]
  • Post JC, Preston RA, Aul JJ, Larkins-Pettigrew M, Rydquist-White J, Anderson KW, Wadowsky RM, Reagan DR, Walker ES, Kingsley LA, et al. Molecular analysis of bacterial pathogens in otitis media with effusion. JAMA. 1995 May 24;273(20):1598–1604. [PubMed]
  • Prallet B, Lucht F, Alexandre C. Vertebral osteomyelitis due to Branhamella catarrhalis. Rev Infect Dis. 1991 Jul-Aug;13(4):769–769. [PubMed]
  • Prellner K, Christensen P, Hovelius B, Rosén C. Nasopharyngeal carriage of bacteria in otitis-prone and non-otitis-prone children in day-care centres. Acta Otolaryngol. 1984 Sep-Oct;98(3-4):343–350. [PubMed]
  • Pukander JS, Jero JP, Kaprio EA, Sorri MJ. Clarithromycin vs. amoxicillin suspensions in the treatment of pediatric patients with acute otitis media. Pediatr Infect Dis J. 1993 Dec;12(12 Suppl 3):S118–S121. [PubMed]
  • Relman DA, Domenighini M, Tuomanen E, Rappuoli R, Falkow S. Filamentous hemagglutinin of Bordetella pertussis: nucleotide sequence and crucial role in adherence. Proc Natl Acad Sci U S A. 1989 Apr;86(8):2637–2641. [PubMed]
  • Richards SJ, Greening AP, Enright MC, Morgan MG, McKenzie H. Outbreak of Moraxella catarrhalis in a respiratory unit. Thorax. 1993 Jan;48(1):91–92. [PMC free article] [PubMed]
  • Rikitomi N, Andersson B, Matsumoto K, Lindstedt R, Svanborg C. Mechanism of adherence of Moraxella (Branhamella) catarrhalis. Scand J Infect Dis. 1991;23(5):559–567. [PubMed]
  • Roberts MC, Pang YJ, Spencer RC, Winstanley TG, Brown BA, Wallace RJ., Jr Tetracycline resistance in Moraxella (Branhamella) catarrhalis: demonstration of two clonal outbreaks by using pulsed-field gel electrophoresis. Antimicrob Agents Chemother. 1991 Nov;35(11):2453–2455. [PMC free article] [PubMed]
  • Rotta AT, Asmar BI. Moraxella catarrhalis bacteremia and preseptal cellulitis. South Med J. 1994 Apr;87(4):541–542. [PubMed]
  • Ruuskanen O, Heikkinen T. Otitis media: etiology and diagnosis. Pediatr Infect Dis J. 1994 Jan;13(1 Suppl 1):S23–S54. [PubMed]
  • Sanyal SK, Wilson N, Twum-Danso K, Abomelha A, Sohel S. Moraxella endocarditis following balloon angioplasty of aortic coarctation. Am Heart J. 1990 Jun;119(6):1421–1423. [PubMed]
  • Sarwar J, Campagnari AA, Kirkham C, Murphy TF. Characterization of an antigenically conserved heat-modifiable major outer membrane protein of Branhamella catarrhalis. Infect Immun. 1992 Mar;60(3):804–809. [PMC free article] [PubMed]
  • Sethi S, Hill SL, Murphy TF. Serum antibodies to outer membrane proteins (OMPs) of Moraxella (Branhamella) catarrhalis in patients with bronchiectasis: identification of OMP B1 as an important antigen. Infect Immun. 1995 Apr;63(4):1516–1520. [PMC free article] [PubMed]
  • Shurin PA, Pelton SI, Tager IB, Kasper DL. Bactericidal antibody and susceptibility to otitis media caused by nontypable strains of Haemophilus influenzae. J Pediatr. 1980 Sep;97(3):364–369. [PubMed]
  • Shurin PA, Rehmus JM, Johnson CE, Marchant CD, Carlin SA, Super DM, Van Hare GF, Jones PK, Ambrosino DM, Siber GR. Bacterial polysaccharide immune globulin for prophylaxis of acute otitis media in high-risk children. J Pediatr. 1993 Nov;123(5):801–810. [PubMed]
  • Smith GL. Branhamella catarrhalis infection imitating gonorrhea in a man. N Engl J Med. 1987 May 14;316(20):1277–1277. [PubMed]
  • Smith JM, Lockwood BM. A 2-year survey of Branhamella catarrhalis in a general hospital. J Hosp Infect. 1986 May;7(3):277–282. [PubMed]
  • Soto-Hernandez JL, Holtsclaw-Berk S, Harvill LM, Berk SL. Phenotypic characteristics of Branhamella catarrhalis strains. J Clin Microbiol. 1989 May;27(5):903–908. [PMC free article] [PubMed]
  • Srikumar R, Dahan D, Gras MF, Ratcliffe MJ, van Alphen L, Coulton JW. Antigenic sites on porin of Haemophilus influenzae type b: mapping with synthetic peptides and evaluation of structure predictions. J Bacteriol. 1992 Jun;174(12):4007–4016. [PMC free article] [PubMed]
  • Srinivasan G, Raff MJ, Templeton WC, Givens SJ, Graves RC, Melo JC. Branhamella catarrhalis pneumonia: report of two cases and review of the literature. Am Rev Respir Dis. 1981 May;123(5):553–555. [PubMed]
  • Stenfors LE, Räisänen S. Quantitative analysis of the bacterial findings in otitis media. J Laryngol Otol. 1990 Oct;104(10):749–757. [PubMed]
  • Stenfors LE, Räisänen S. Abundant attachment of bacteria to nasopharyngeal epithelium in otitis-prone children. J Infect Dis. 1992 Jun;165(6):1148–1150. [PubMed]
  • Stenfors LE, Räisänen S. Secretory IgA-, IgG- and C3b-coated bacteria in the nasopharynx of otitis-prone and non-otitis-prone children. Acta Otolaryngol. 1993 Mar;113(2):191–195. [PubMed]
  • St Geme JW, 3rd, Falkow S, Barenkamp SJ. High-molecular-weight proteins of nontypable Haemophilus influenzae mediate attachment to human epithelial cells. Proc Natl Acad Sci U S A. 1993 Apr 1;90(7):2875–2879. [PubMed]
  • Stool SE, Field MJ. The impact of otitis media. Pediatr Infect Dis J. 1989 Jan;8(1 Suppl):S11–S14. [PubMed]
  • Suzuki K, Bakaletz LO. Synergistic effect of adenovirus type 1 and nontypeable Haemophilus influenzae in a chinchilla model of experimental otitis media. Infect Immun. 1994 May;62(5):1710–1718. [PMC free article] [PubMed]
  • Tuomanen E, Weiss A. Characterization of two adhesins of Bordetella pertussis for human ciliated respiratory-epithelial cells. J Infect Dis. 1985 Jul;152(1):118–125. [PubMed]
  • Ueyama T, Kurono Y, Shirabe K, Takeshita M, Mogi G. High incidence of Haemophilus influenzae in nasopharyngeal secretions and middle ear effusions as detected by PCR. J Clin Microbiol. 1995 Jul;33(7):1835–1838. [PMC free article] [PubMed]
  • Unhanand M, Maciver I, Ramilo O, Arencibia-Mireles O, Argyle JC, McCracken GH, Jr, Hansen EJ. Pulmonary clearance of Moraxella catarrhalis in an animal model. J Infect Dis. 1992 Apr;165(4):644–650. [PubMed]
  • Urisu A, Cowell JL, Manclark CR. Filamentous hemagglutinin has a major role in mediating adherence of Bordetella pertussis to human WiDr cells. Infect Immun. 1986 Jun;52(3):695–701. [PMC free article] [PubMed]
  • Vaneechoutte M, Verschraegen G, Claeys G, Van Den Abeele AM. Serological typing of Branhamella catarrhalis strains on the basis of lipopolysaccharide antigens. J Clin Microbiol. 1990 Feb;28(2):182–187. [PMC free article] [PubMed]
  • Vaneechoutte M, Verschraegen G, Claeys G, Weise B, Van den Abeele AM. Respiratory tract carrier rates of Moraxella (Branhamella) catarrhalis in adults and children and interpretation of the isolation of M. catarrhalis from sputum. J Clin Microbiol. 1990 Dec;28(12):2674–2680. [PMC free article] [PubMed]
  • Van Hare GF, Shurin PA, Marchant CD, Cartelli NA, Johnson CE, Fulton D, Carlin S, Kim CH. Acute otitis media caused by Branhamella catarrhalis: biology and therapy. Rev Infect Dis. 1987 Jan-Feb;9(1):16–27. [PubMed]
  • Verduin CM, Jansze M, Hol C, Mollnes TE, Verhoef J, van Dijk H. Differences in complement activation between complement-resistant and complement-sensitive Moraxella (Branhamella) catarrhalis strains occur at the level of membrane attack complex formation. Infect Immun. 1994 Feb;62(2):589–595. [PMC free article] [PubMed]
  • Verghese A, Berro E, Berro J, Franzus BW. Pulmonary clearance and phagocytic cell response in a murine model of Branhamella catarrhalis infection. J Infect Dis. 1990 Nov;162(5):1189–1192. [PubMed]
  • Verghese A, Roberson D, Kalbfleisch JH, Sarubbi F. Randomized comparative study of cefixime versus cephalexin in acute bacterial exacerbations of chronic bronchitis. Antimicrob Agents Chemother. 1990 Jun;34(6):1041–1044. [PMC free article] [PubMed]
  • Verheul AF, Snippe H, Poolman JT. Meningococcal lipopolysaccharides: virulence factor and potential vaccine component. Microbiol Rev. 1993 Mar;57(1):34–49. [PMC free article] [PubMed]
  • Vernham GA, Crowther JA. Acute myeloid leukaemia presenting with acute Branhamella catarrhalis epiglottitis. J Infect. 1993 Jan;26(1):93–95. [PubMed]
  • Virolainen A, Salo P, Jero J, Karma P, Eskola J, Leinonen M. Comparison of PCR assay with bacterial culture for detecting Streptococcus pneumoniae in middle ear fluid of children with acute otitis media. J Clin Microbiol. 1994 Nov;32(11):2667–2670. [PMC free article] [PubMed]
  • von Graevenitz A, Rathbone RR. Branhamella catarrhalis in respiratory secretions: clinical correlation in 16 cases. South Med J. 1981 Sep;74(9):1095–1096. [PubMed]
  • Wald ER, Reilly JS, Casselbrant M, Ledesma-Medina J, Milmoe GJ, Bluestone CD, Chiponis D. Treatment of acute maxillary sinusitis in childhood: a comparative study of amoxicillin and cefaclor. J Pediatr. 1984 Feb;104(2):297–302. [PubMed]
  • Wallace MR, Oldfield EC., 3rd Moraxella (Branhamella) catarrhalis bacteremia. A case report and literature review. Arch Intern Med. 1990 Jun;150(6):1332–1334. [PubMed]
  • Weiser JN. The oligosaccharide of Haemophilus influenzae. Microb Pathog. 1992 Nov;13(5):335–342. [PubMed]
  • Weiss MS, Abele U, Weckesser J, Welte W, Schiltz E, Schulz GE. Molecular architecture and electrostatic properties of a bacterial porin. Science. 1991 Dec 13;254(5038):1627–1630. [PubMed]
  • West M, Berk SL, Smith JK. Branhamella catarrhalis pneumonia. South Med J. 1982 Aug;75(8):1021–1023. [PubMed]
  • Wright PW, Wallace RJ., Jr Pneumonia due to Moraxella (Branhamella) catarrhalis. Semin Respir Infect. 1989 Mar;4(1):40–46. [PubMed]
  • Yu RH, Schryvers AB. The interaction between human transferrin and transferrin binding protein 2 from Moraxella (Branhamella) catarrhalis differs from that of other human pathogens. Microb Pathog. 1993 Dec;15(6):433–445. [PubMed]

Articles from Microbiological Reviews are provided here courtesy of American Society for Microbiology (ASM)